Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.
-
The case alleges Richtech Robotics claimed that it had a collaborative and commercial relationship with Microsoft when it did not.
-
$FRMI FRMI Fermi Fermi Inc. Fermi Class Action Lawsuit BW: $FRMI FRMI Fermi FermiInc. FermiClassActionLawsuit The case alleges Fermi Inc. misled investors
-
Oracle allegedly failed to disclose that its AI strategy would result in massive increases in CapEx without equivalent near-term revenue growth.
-
The lawsuit alleges that Masonite had an obligation to disclose it had received formal acquisition offers or abstain from purchasing Masonite stock.
-
Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.
-
Oracle allegedly failed to disclose that its AI strategy would result in massive increases in CapEx without equivalent near-term revenue growth.
-
The law firm of Robbins Geller is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT).
-
The BlackRock TCP class action lawsuit alleges that BlackRock TCP’s NAV was overstated.
-
The CoreWeave class action alleges that defendants overstated CoreWeave’s ability to meet customer demand for its service.